High initiation and persistence on pre-exposure prophylaxis (PrEP) has been documented in pregnant women in Cape Town, South Africa, with 91% of those offered PrEP starting it and nearly half of those continuing to take PrEP six months later. While women who had given birth and those reporting side effects were less likely to stay… Read More: High rates of starting and staying on PrEP in pregnant… »
Professor Larry Corey, principal researcher of the AMP studies, speaking at HIVR4P Two years ago, at the HIV Research for Prevention (HIVR4P) conference in Madrid, Professor Lynn Morris of the South African National Institute for Communicable Diseases made a prediction about the AMP (Antibody-Mediated Protection) studies. The two studies are the first large studies using injections every… Read More: Antibody-based PrEP did not stop most types of HIV –… »
New HIV diagnoses in gay and bisexual men fell by 20% after the implementation of a publicly funded PrEP programme in Scotland, while HIV incidence in a large cohort of men attending sexual health clinics fell by 43%, Professor Claudia Estcourt of Glasgow Caledonian University and colleagues report in AIDS. “We show that it is… Read More: Huge fall in new HIV infections after roll-out of PrEP… »
Australian doctors and nurses discuss PrEP’s role in tackling stigma, supporting U=U, and improving mental health Do doctors and other healthcare workers feel it’s legitimate to prescribe PrEP to people who are anxious about catching HIV, even if their actual risk is low? This question has been rarely been systematically asked of doctors and other… Read More: Is reducing anxiety a legitimate indication for PrEP in itself? »